Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer
Clinical trial NCT02138383 · COMPLETED
Trial details
- NCT number
- NCT02138383
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-22
- Primary completion
- 2016-12-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.